No.

PRODUCTS

CAS No.

INDICATIONS

Remark

1

Ibrutinib

936563-96-1

Oncology

DMF

2

Ruxolitinib

941678-49-5

Myelofibrosis

DMF*

3

Elagolix

834153-87-6

Endometriosis,Uterine leiomyoma

TDP

4

Relugolix

737789-87-6

Endometriosis
Uterine leiomyoma,

Prostate cancer

TDP

5

Ibrutinib

936563-96-1

MCL & WM

DMF

6

Cabozantinib

849217-68-1

Multi-targeted tyrosine kinase

DMF

7

Tucatinib

937263-43-9

Anti-breast cancer

DMF